Establishing prostate cancer patient derived xenografts: Lessons learned from older studies-Reference-Cited by-同舟云学术

Establishing prostate cancer patient derived xenografts: Lessons learned from older studies

Published:2015-01-05 Issue:6 Volume:75 Page:628-636
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Russell Pamela J.¹,Russell Peter²³,Rudduck Christina⁴,Tse Brian W‐C¹,Williams Elizabeth D.¹,Raghavan Derek⁵

Affiliation:

1. Australian Prostate Cancer Research Centre ‐ QueenslandInstitute of Health and Biomedical InnovationQueensland University of TechnologyTranslational Research InstituteBrisbaneQueensland 4102,Australia

2. GynaePathDouglass Hanly Moir PathologyMacquarie ParkNew South WalesAustralia

3. Department of Obstetrics Gynaecology and NeonatologyUniversity of Sydney, SydneyNew South WalesAustralia

4. Cytogenetics DepartmentThe Children's HospitalSydneyNew South WalesAustralia

5. Levine Cancer InstituteCharlotteNorth Carolina

Publisher

Wiley

Subject

Urology,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pros.22946

Reference48 articles.

1. Global cancer statistics

2. New Strategies in Metastatic Prostate Cancer: Targeting the Androgen Receptor Signaling Pathway

3. Characterising the castration-resistant prostate cancer population: a systematic review

4. Innovations in the systemic therapy of prostate cancer

5. Bladder cancer xenografts: A model of tumor cell heterogeneity;Russell PJ;Cancer Res,1986

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sensitivity of magnetic resonance elastography to extracellular matrix and cell motility in human prostate cancer cell line-derived xenograft models;Biomaterials Advances;2024-07

2. Pre-Clinical Models to Study Human Prostate Cancer;Cancers;2023-08-22

3. The future of patient-derived xenografts in prostate cancer research;Nature Reviews Urology;2023-01-17

4. Establishment of an Ex Vivo Tissue Culture Model for Evaluation of Antitumor Efficacy in Clear Cell Renal Cell Carcinoma;Frontiers in Oncology;2022-04-06

5. Use of conditional reprogramming cell, patient derived xenograft and organoid for drug screening for individualized prostate cancer therapy: Current and future perspectives (Review);International Journal of Oncology;2022-03-24